SOMANETICS CORPORATION (NASDAQ: SMTS)





$15.81 0.18 (1.15%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
18.70
52-Week Low Price
10.18
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.19 B
P/E Ratio (TTM)
29.5
Diluted EPS (TTM)
0.45
Shares
11.95 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 7% - SMTS has underperformed the S&P 500 by 19%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
STEREOTAXIS INC (STXS) $4.25 -  $0.06(1.43%)0.20 B
CARDO MEDICAL INC (CDOM) $0.96 -  $0.00(0.00%)0.20 B
TOMOTHERAPY INC (TOMO) $3.89 -  $0.17(4.57%)0.22 B
IRIS INTERNATIONAL INC (IRIS) $10.67 -  $0.14(1.33%)0.19 B
MEASUREMENT SPECIALTIES (MEAS) $12.92 -  $0.10(0.77%)0.19 B
MOVADO GROUP INC CL CM (MOV) $10.84 -  $0.39(3.73%)0.19 B
LA BARGE INC (LB) $10.66 -  $0.10(0.95%)0.17 B
HERLEY INDUSTRIES INC (HRLY) $12.17 -  $0.37(3.14%)0.16 B
NEOPROBE CORP (NEOP) $2.17 -  $0.14(6.90%)0.15 B
CALIPER LIFE SCIENCES (CALP) $3.15 -  $0.00(0.00%)0.15 B
STOCK ANALYSIS
There are currently no Stock Analysis.
SMTS RELATED HEADLINES
arrow
Biotech Stocks
<ul> <li>Rodman &amp; Renshaw Annual Global Investment Conference</li> <li>Chelsea Therapeutics drops Droxidopa in Phase II</li> <li>Javelin discuss their Phase III products Dyloject, Ereska, and Rylomine</li> <ul>

Wall Street Media 11/11/2008
arrow
Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
- Somanetics to Webcast Presentation on November 10, 2008 at 4:30 P.M. ET -

Forbes.com 11/3/2008
arrow
BRIEF-Somanetics Q3 results

Forbes.com 9/17/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2